Guardant Health, Inc. (GH) research
Guardant Health, Inc.- Sector
- Health Care
- Last price
- $177.80
- As of
Guardant Health, Inc. (GH): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-07-30.
As of . Source: SEC EDGAR filings for GH. Method and limitations.
Share the GH intelligence card
See the full GH dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for GH on one page. Preview it with sample data, then open it live with a free account.
Preview the GH dossierActive signals for GH
- highCONSENSUS_BUY
6 tracked funds increased GH this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +222% to GH (2026Q2)
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +9017% to GH (2026Q2)
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +1604% to GH (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +92% to GH (2026Q2)
FREE, NO ACCOUNT
Every signal on GH, as it fires
You are seeing 5 of 24 signals recorded on GH since 2026-06-18.
The five above landed across 2 days. The other 19 were recorded on 3 other days. 18 of the 24 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in GH (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| TWO SIGMA INVESTMENTS, LPCUSIP 40131M109 · 2026Q2 | $558M | 0.40% | , |
| D. E. Shaw & Co., Inc.CUSIP 40131MAD1 · 2026Q2 | $263.1M | 0.13% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 40131M109 · 2026Q2 | $243.4M | 0.09% | , |
| CITADEL ADVISORS LLCCUSIP 40131M109 · 2026Q2 | $217.5M | 0.02% | , |
| D. E. Shaw & Co., Inc.CUSIP 40131M109 · 2026Q2 | $188.4M | 0.09% | , |
| Point72 Asset Management, L.P.CUSIP 40131M109 · 2026Q2 | $138.1M | 0.15% | , |
| D. E. Shaw & Co., Inc.CUSIP 40131MAB5 · 2026Q2 | $87.8M | 0.04% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 40131MAB5 · 2026Q2 | $7.5M | 0.00% | , |
| Bridgewater Associates, LPCUSIP 40131M109 · 2026Q2 | $637K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, GH
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
GH against its peers
GH's operating margin of -44.5% ranks in the 6th percentile of 24 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.
| Metric | GH | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 982M USD | 2.0B USD | 17 | 25 |
| Gross margin | n/a | 61.1% | n/a | 17 |
| Operating margin | -44.5% | 10.1% | 6 | 24 |
| Net margin | -42.4% | 5.5% | 10 | 25 |
| Return on equity | n/a | 10.8% | n/a | 25 |
| P / E | n/a | 40.1x | n/a | 17 |
Peers (25): THC, MDLN, VEEV, PEN, EHC, BTSG, ENSG, MOH, MASI, GKOS, HNGE, HIMS, PACS, CHE, LNTH, RDNT, TFX, MMSI, DOCS, WAY, HAE, ITGR, LIVN, NVST, IRTC. Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (GH: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more GH signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to GHand get the insider, 13F, options, and confluence read in one view.